Skip to main content

People in the News: Chee Gee See, Jeffrey Bishop, Linda Greub

Premium

Proteome Sciences said this week it had appointed Chee Gee See director of personalized medicine.

Previously Gee See was a biomarker and experimental medicine leader at Roche. Before that he was an analyst at GlaxoSmithKline.


Singulex said this week that it has appointed Jeffrey Bishop vice president, research and development and Linda Greub vice president, business development.

Bishop was previously vice president, research and development at Alere.

Greub was previously global director of strategy, business development at Novartis. Prior to that she was senior director, strategy and business development at Applied Biosystems as well as a senior healthcare analyst for several investment banks and hedge funds.

The Scan

US Supports Patent Waivers

NPR reports that the Biden Administration has announced its support for waiving intellectual property protections for SARS-CoV-2 vaccines.

Vaccines Versus Variants

Two studies find the Pfizer-BioNTech SARS-CoV-2 vaccine to be effective against viral variants, and Moderna reports on booster shots to combat variants.

CRISPR for What Ails You

The Wall Street Journal writes that CRISPR-based therapies could someday be used to treat common conditions like heart attacks.

Nature Papers Review Integration of Single-Cell Assay Data, Present Approach to Detect Rare Variants

In Nature this week: review of ways to integrate data from single-cell assays, and more.